Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
Clinical trial NCT02291848 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02291848
- Sponsor
- Baylor College of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2026-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.